Summary
Personalised Medicine supports patients in receiving an optimal and effective treatment with a minimum of risk of adverse events.
As this type of treatment is still relatively new, many have the need for an introduction to the basics of personalised medicine: what is the potential? What types of analyses are needed? What is the flow in collaboration and responsibilities among stakeholders, e.g. doctors, analysts and patients?
By completing the 7 modules included in this self-access online course, you acquire basic knowledge about personalised medicine: The potential of genetic analysis of drug metabolising enzymes, transporters and receptors, and how to use this information in clinical practice.
You can access the 7 online modules whenever is most convenient for you. Please note that your access expires one year from the time you sign up.
After finishing each module, you must answer a number of questions related to that specific module before you can access the next module.
After completing the 7 modules, you have the possibility to join 3 online follow-up Q&A sessions with the experts who prepared the modules. You will be able to sign up for 3 sessions of 1 hours duration within a year from your completion of the 7 modules. The Q&A sessions are based on your questions and are included in the course price.
Key words
- Personalised medicine
- Optimised medical treatment
- Reduction of adverse events
- Pharmacogenomics
- Pharmacokinetics
- Pharmacodynamics
IS THIS COURSE FOR YOU?
The course is for you, if you wish to understand the potential and principles of personalised medicine and work within the healthcare sector as a general practitioner, specialist, nurse, pharmacist or researcher, and you are interested in personalised medical treatment.
What you will learn
- Module 1: How pharmacogenomic testing can support the healthcare system in providing the right medical treatment, to the right patient, in the right dose, at the right time.
- Module 2: Legal aspects in relation to ethics and GDPR.
- Module 3: How pharmacogenomic data can be translated and applied in the clinic. And the internationally peer-reviewed pharmacogenetic databases, treatment guidelines and regulatory framework that will guide your way.
- Module 4: Factors beyond pharmacokinetics and pharmacodynamics, e.g. how genetic variation can help shed light on different responses to drugs between patients.
- Module 5: The analytical aspects in the laboratory: what is the laboratory process flow? How is the genotype translated into the phenotype? What are the limitations and advantages of several platforms?
- Module 6: Pharmacogenomics is not something in the future – it is here today. Patients can already benefit from personalised medicine, e.g. capecitabine/DPYD, clopidogrel/CYP2C19, antidepressants/CYP2D6, pain/CYP2D6 and more.
- Module 7: Pharmacogenomics is only one factor that affects the dose-response relationship of drugs. Co-medication, kidney function, lifestyle etc. are well-known contributors affecting the dose-response relationship of drugs.
What your company will get
- An employee with an understanding of personalised medicine in relation to pharmacogenomics, pharmacokinetics and pharmacodynamics, legal aspects, regulatory framework and clinical utility.
Course agenda
Module 1:
How pharmacogenomic testing can support the healthcare system in providing the right medical treatment, to the right patient, in the right dose, at the right time..
Module 2:
Legal aspects in relation to ethics and GDPR.
Module 3:
How pharmacogenomic data can be translated and applied in the clinic. And the internationally peer-reviewed pharmacogenetic databases, treatment guidelines and regulatory framework that will guide your way.
Module 4:
Factors beyond pharmacokinetics and pharmacodynamics, e.g. how genetic variation can help shed light on different responses to drugs between patients.
Module 5:
The analytical aspects in the laboratory: what is the laboratory process flow? How is the genotype translated into the phenotype? What are the limitations and advantages of several platforms?
Module 6:
Pharmacogenomics is not something in the future – it is here today. Patients can already benefit from personalised medicine, e.g. capecitabine/DPYD, clopidogrel/CYP2C19, antidepressants/CYP2D6, pain/CYP2D6 and more.
Module 7:
Pharmacogenomics is only one factor that affects the dose-response relationship of drugs. Co-medication, kidney function, lifestyle etc. are well-known contributors affecting the dose-response relationship of drugs.
Registration
Registration deadline25. Dec 2025
You may also be interested in these courses
Want to know more or need help?
Contact Client Manager Christina Spangsberg at +45 39 15 09 22
Send me a message